nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranolazine—SCN5A—dilated cardiomyopathy	0.804	1	CbGaD
Ranolazine—SCN5A—purkinje fiber—dilated cardiomyopathy	0.0498	0.467	CbGeAlD
Ranolazine—SCN5A—endocardium—dilated cardiomyopathy	0.0257	0.241	CbGeAlD
Ranolazine—SCN5A—sinoatrial node—dilated cardiomyopathy	0.0243	0.228	CbGeAlD
Ranolazine—SCN5A—cardiac ventricle—dilated cardiomyopathy	0.00216	0.0203	CbGeAlD
Ranolazine—SCN5A—myocardium—dilated cardiomyopathy	0.00203	0.0191	CbGeAlD
Ranolazine—SCN9A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.002	0.23	CbGpPWpGaD
Ranolazine—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00174	0.0236	CcSEcCtD
Ranolazine—Lethargy—Spironolactone—dilated cardiomyopathy	0.00164	0.0222	CcSEcCtD
Ranolazine—Carvedilol—NPPB—dilated cardiomyopathy	0.00148	0.232	CrCbGaD
Ranolazine—Carvedilol—GJA1—dilated cardiomyopathy	0.00148	0.232	CrCbGaD
Ranolazine—Serum creatinine increased—Lisinopril—dilated cardiomyopathy	0.00147	0.0199	CcSEcCtD
Ranolazine—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00145	0.0196	CcSEcCtD
Ranolazine—SCN5A—heart—dilated cardiomyopathy	0.00142	0.0133	CbGeAlD
Ranolazine—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00138	0.0186	CcSEcCtD
Ranolazine—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00128	0.0173	CcSEcCtD
Ranolazine—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00127	0.0171	CcSEcCtD
Ranolazine—Renal failure—Spironolactone—dilated cardiomyopathy	0.00122	0.0165	CcSEcCtD
Ranolazine—Ropivacaine—SCN5A—dilated cardiomyopathy	0.00122	0.191	CrCbGaD
Ranolazine—SCN5A—cardiac atrium—dilated cardiomyopathy	0.00121	0.0114	CbGeAlD
Ranolazine—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.000951	0.0129	CcSEcCtD
Ranolazine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000932	0.0126	CcSEcCtD
Ranolazine—Lethargy—Furosemide—dilated cardiomyopathy	0.000894	0.0121	CcSEcCtD
Ranolazine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000868	0.0117	CcSEcCtD
Ranolazine—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.000855	0.0116	CcSEcCtD
Ranolazine—Urinary retention—Furosemide—dilated cardiomyopathy	0.000833	0.0113	CcSEcCtD
Ranolazine—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.000821	0.0111	CcSEcCtD
Ranolazine—Dehydration—Furosemide—dilated cardiomyopathy	0.000815	0.011	CcSEcCtD
Ranolazine—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.0008	0.0108	CcSEcCtD
Ranolazine—Confusional state—Spironolactone—dilated cardiomyopathy	0.000798	0.0108	CcSEcCtD
Ranolazine—Cramp muscle—Furosemide—dilated cardiomyopathy	0.000789	0.0107	CcSEcCtD
Ranolazine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000775	0.0105	CcSEcCtD
Ranolazine—SCN5A—Cardiac Progenitor Differentiation—MYH6—dilated cardiomyopathy	0.000768	0.0883	CbGpPWpGaD
Ranolazine—SCN9A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.000767	0.0881	CbGpPWpGaD
Ranolazine—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00075	0.0101	CcSEcCtD
Ranolazine—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000742	0.01	CcSEcCtD
Ranolazine—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.000712	0.00963	CcSEcCtD
Ranolazine—Somnolence—Spironolactone—dilated cardiomyopathy	0.000704	0.00951	CcSEcCtD
Ranolazine—SCN5A—Cardiac Progenitor Differentiation—TNNI3—dilated cardiomyopathy	0.000685	0.0787	CbGpPWpGaD
Ranolazine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000683	0.00924	CcSEcCtD
Ranolazine—Renal failure—Furosemide—dilated cardiomyopathy	0.000664	0.00897	CcSEcCtD
Ranolazine—Bevantolol—ADRB1—dilated cardiomyopathy	0.000662	0.104	CrCbGaD
Ranolazine—Diplopia—Lisinopril—dilated cardiomyopathy	0.000657	0.00889	CcSEcCtD
Ranolazine—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.000657	0.00889	CcSEcCtD
Ranolazine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000652	0.00882	CcSEcCtD
Ranolazine—Urticaria—Spironolactone—dilated cardiomyopathy	0.000629	0.0085	CcSEcCtD
Ranolazine—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.000616	0.00833	CcSEcCtD
Ranolazine—Dehydration—Lisinopril—dilated cardiomyopathy	0.000611	0.00826	CcSEcCtD
Ranolazine—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.0006	0.00812	CcSEcCtD
Ranolazine—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000598	0.00809	CcSEcCtD
Ranolazine—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000594	0.00803	CcSEcCtD
Ranolazine—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000594	0.00803	CcSEcCtD
Ranolazine—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000592	0.008	CcSEcCtD
Ranolazine—Visual impairment—Furosemide—dilated cardiomyopathy	0.000584	0.0079	CcSEcCtD
Ranolazine—SCN5A—Cardiac Progenitor Differentiation—TNNT2—dilated cardiomyopathy	0.000582	0.0669	CbGpPWpGaD
Ranolazine—SCN5A—Cardiac Progenitor Differentiation—ACTC1—dilated cardiomyopathy	0.000582	0.0669	CbGpPWpGaD
Ranolazine—Eye disorder—Furosemide—dilated cardiomyopathy	0.000566	0.00766	CcSEcCtD
Ranolazine—Tinnitus—Furosemide—dilated cardiomyopathy	0.000565	0.00764	CcSEcCtD
Ranolazine—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000562	0.0076	CcSEcCtD
Ranolazine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00056	0.00757	CcSEcCtD
Ranolazine—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000557	0.00753	CcSEcCtD
Ranolazine—Bevantolol—ADRB2—dilated cardiomyopathy	0.000557	0.0873	CrCbGaD
Ranolazine—Angiopathy—Furosemide—dilated cardiomyopathy	0.00055	0.00743	CcSEcCtD
Ranolazine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000541	0.00732	CcSEcCtD
Ranolazine—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000539	0.00729	CcSEcCtD
Ranolazine—Dysuria—Lisinopril—dilated cardiomyopathy	0.000531	0.00718	CcSEcCtD
Ranolazine—Malnutrition—Furosemide—dilated cardiomyopathy	0.000528	0.00713	CcSEcCtD
Ranolazine—Dizziness—Spironolactone—dilated cardiomyopathy	0.000523	0.00708	CcSEcCtD
Ranolazine—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000523	0.00707	CcSEcCtD
Ranolazine—Flatulence—Furosemide—dilated cardiomyopathy	0.00052	0.00703	CcSEcCtD
Ranolazine—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000514	0.00695	CcSEcCtD
Ranolazine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000507	0.00686	CcSEcCtD
Ranolazine—Vomiting—Spironolactone—dilated cardiomyopathy	0.000503	0.0068	CcSEcCtD
Ranolazine—Rash—Spironolactone—dilated cardiomyopathy	0.000499	0.00675	CcSEcCtD
Ranolazine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000499	0.00674	CcSEcCtD
Ranolazine—Renal failure—Lisinopril—dilated cardiomyopathy	0.000498	0.00673	CcSEcCtD
Ranolazine—Vision blurred—Furosemide—dilated cardiomyopathy	0.000497	0.00672	CcSEcCtD
Ranolazine—Headache—Spironolactone—dilated cardiomyopathy	0.000496	0.0067	CcSEcCtD
Ranolazine—Haematuria—Lisinopril—dilated cardiomyopathy	0.000483	0.00653	CcSEcCtD
Ranolazine—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000478	0.00646	CcSEcCtD
Ranolazine—Vertigo—Furosemide—dilated cardiomyopathy	0.000474	0.00641	CcSEcCtD
Ranolazine—Leukopenia—Furosemide—dilated cardiomyopathy	0.000472	0.00638	CcSEcCtD
Ranolazine—Nausea—Spironolactone—dilated cardiomyopathy	0.00047	0.00636	CcSEcCtD
Ranolazine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000463	0.00626	CcSEcCtD
Ranolazine—Hallucination—Lisinopril—dilated cardiomyopathy	0.000452	0.00612	CcSEcCtD
Ranolazine—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000449	0.00607	CcSEcCtD
Ranolazine—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000448	0.00606	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000446	0.00603	CcSEcCtD
Ranolazine—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000446	0.00603	CcSEcCtD
Ranolazine—Dry mouth—Furosemide—dilated cardiomyopathy	0.000439	0.00594	CcSEcCtD
Ranolazine—Confusional state—Furosemide—dilated cardiomyopathy	0.000434	0.00587	CcSEcCtD
Ranolazine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000424	0.00573	CcSEcCtD
Ranolazine—Shock—Furosemide—dilated cardiomyopathy	0.000424	0.00573	CcSEcCtD
Ranolazine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000422	0.00571	CcSEcCtD
Ranolazine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000422	0.0057	CcSEcCtD
Ranolazine—Skin disorder—Furosemide—dilated cardiomyopathy	0.000418	0.00565	CcSEcCtD
Ranolazine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000416	0.00563	CcSEcCtD
Ranolazine—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000413	0.00558	CcSEcCtD
Ranolazine—Anorexia—Furosemide—dilated cardiomyopathy	0.00041	0.00555	CcSEcCtD
Ranolazine—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00041	0.00554	CcSEcCtD
Ranolazine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000406	0.00549	CcSEcCtD
Ranolazine—Hypotension—Furosemide—dilated cardiomyopathy	0.000402	0.00544	CcSEcCtD
Ranolazine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000398	0.00539	CcSEcCtD
Ranolazine—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000396	0.00535	CcSEcCtD
Ranolazine—Flatulence—Lisinopril—dilated cardiomyopathy	0.00039	0.00527	CcSEcCtD
Ranolazine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000387	0.00523	CcSEcCtD
Ranolazine—Somnolence—Furosemide—dilated cardiomyopathy	0.000383	0.00518	CcSEcCtD
Ranolazine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000381	0.00515	CcSEcCtD
Ranolazine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000374	0.00506	CcSEcCtD
Ranolazine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000373	0.00504	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000372	0.00503	CcSEcCtD
Ranolazine—Fatigue—Furosemide—dilated cardiomyopathy	0.000371	0.00502	CcSEcCtD
Ranolazine—Tremor—Lisinopril—dilated cardiomyopathy	0.000371	0.00501	CcSEcCtD
Ranolazine—Constipation—Furosemide—dilated cardiomyopathy	0.000368	0.00498	CcSEcCtD
Ranolazine—Angioedema—Lisinopril—dilated cardiomyopathy	0.000362	0.00489	CcSEcCtD
Ranolazine—Vertigo—Lisinopril—dilated cardiomyopathy	0.000356	0.00481	CcSEcCtD
Ranolazine—Syncope—Lisinopril—dilated cardiomyopathy	0.000355	0.0048	CcSEcCtD
Ranolazine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000355	0.0048	CcSEcCtD
Ranolazine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000354	0.00479	CcSEcCtD
Ranolazine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000352	0.00476	CcSEcCtD
Ranolazine—Palpitations—Lisinopril—dilated cardiomyopathy	0.00035	0.00473	CcSEcCtD
Ranolazine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000348	0.0047	CcSEcCtD
Ranolazine—Cough—Lisinopril—dilated cardiomyopathy	0.000345	0.00467	CcSEcCtD
Ranolazine—Urticaria—Furosemide—dilated cardiomyopathy	0.000342	0.00462	CcSEcCtD
Ranolazine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00034	0.0046	CcSEcCtD
Ranolazine—Anxiety—Lisinopril—dilated cardiomyopathy	0.000336	0.00454	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000335	0.00452	CcSEcCtD
Ranolazine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00033	0.00446	CcSEcCtD
Ranolazine—Confusional state—Lisinopril—dilated cardiomyopathy	0.000326	0.0044	CcSEcCtD
Ranolazine—Shock—Lisinopril—dilated cardiomyopathy	0.000318	0.0043	CcSEcCtD
Ranolazine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000316	0.00428	CcSEcCtD
Ranolazine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000314	0.00424	CcSEcCtD
Ranolazine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000312	0.00422	CcSEcCtD
Ranolazine—Asthenia—Furosemide—dilated cardiomyopathy	0.000309	0.00418	CcSEcCtD
Ranolazine—Anorexia—Lisinopril—dilated cardiomyopathy	0.000308	0.00416	CcSEcCtD
Ranolazine—Pruritus—Furosemide—dilated cardiomyopathy	0.000305	0.00412	CcSEcCtD
Ranolazine—Carvedilol—ADRB1—dilated cardiomyopathy	0.000302	0.0474	CrCbGaD
Ranolazine—Hypotension—Lisinopril—dilated cardiomyopathy	0.000302	0.00408	CcSEcCtD
Ranolazine—Insomnia—Lisinopril—dilated cardiomyopathy	0.000292	0.00395	CcSEcCtD
Ranolazine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00029	0.00392	CcSEcCtD
Ranolazine—SCN9A—Axon guidance—SCN5A—dilated cardiomyopathy	0.00029	0.0333	CbGpPWpGaD
Ranolazine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000288	0.00389	CcSEcCtD
Ranolazine—Somnolence—Lisinopril—dilated cardiomyopathy	0.000287	0.00388	CcSEcCtD
Ranolazine—Dizziness—Furosemide—dilated cardiomyopathy	0.000285	0.00385	CcSEcCtD
Ranolazine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000284	0.00384	CcSEcCtD
Ranolazine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000281	0.0038	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000279	0.00377	CcSEcCtD
Ranolazine—Fatigue—Lisinopril—dilated cardiomyopathy	0.000279	0.00377	CcSEcCtD
Ranolazine—Constipation—Lisinopril—dilated cardiomyopathy	0.000276	0.00373	CcSEcCtD
Ranolazine—Vomiting—Furosemide—dilated cardiomyopathy	0.000274	0.0037	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000273	0.0313	CbGpPWpGaD
Ranolazine—Rash—Furosemide—dilated cardiomyopathy	0.000271	0.00367	CcSEcCtD
Ranolazine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000271	0.00367	CcSEcCtD
Ranolazine—Headache—Furosemide—dilated cardiomyopathy	0.00027	0.00365	CcSEcCtD
Ranolazine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000266	0.0036	CcSEcCtD
Ranolazine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000264	0.00357	CcSEcCtD
Ranolazine—Urticaria—Lisinopril—dilated cardiomyopathy	0.000257	0.00347	CcSEcCtD
Ranolazine—Nausea—Furosemide—dilated cardiomyopathy	0.000256	0.00346	CcSEcCtD
Ranolazine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000255	0.00345	CcSEcCtD
Ranolazine—Carvedilol—ADRB2—dilated cardiomyopathy	0.000254	0.0399	CrCbGaD
Ranolazine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000232	0.00313	CcSEcCtD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000231	0.0265	CbGpPWpGaD
Ranolazine—Propranolol—ADRB1—dilated cardiomyopathy	0.00023	0.0361	CrCbGaD
Ranolazine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000229	0.00309	CcSEcCtD
Ranolazine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000214	0.00289	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000207	0.0238	CbGpPWpGaD
Ranolazine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000205	0.00278	CcSEcCtD
Ranolazine—Rash—Lisinopril—dilated cardiomyopathy	0.000204	0.00275	CcSEcCtD
Ranolazine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000204	0.00275	CcSEcCtD
Ranolazine—Headache—Lisinopril—dilated cardiomyopathy	0.000202	0.00274	CcSEcCtD
Ranolazine—SCN9A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000202	0.0232	CbGpPWpGaD
Ranolazine—Propranolol—ADRB2—dilated cardiomyopathy	0.000193	0.0303	CrCbGaD
Ranolazine—Nausea—Lisinopril—dilated cardiomyopathy	0.000192	0.00259	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.00017	0.0195	CbGpPWpGaD
Ranolazine—SCN9A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000163	0.0187	CbGpPWpGaD
Ranolazine—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000131	0.015	CbGpPWpGaD
Ranolazine—SCN5A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000126	0.0145	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000122	0.014	CbGpPWpGaD
Ranolazine—SCN5A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000101	0.0116	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	9.01e-05	0.0104	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—PSEN2—dilated cardiomyopathy	8.71e-05	0.01	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	7.81e-05	0.00898	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—ITGB1—dilated cardiomyopathy	7.64e-05	0.00878	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—PSEN2—dilated cardiomyopathy	7.61e-05	0.00874	CbGpPWpGaD
Ranolazine—SCN9A—L1CAM interactions—EGFR—dilated cardiomyopathy	7.39e-05	0.00849	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—RAC1—dilated cardiomyopathy	6.14e-05	0.00706	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—ITGB1—dilated cardiomyopathy	5.45e-05	0.00626	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—PSEN2—dilated cardiomyopathy	5.43e-05	0.00624	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—ITGB1—dilated cardiomyopathy	4.76e-05	0.00547	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—CD36—dilated cardiomyopathy	4.65e-05	0.00534	CbGpPWpGaD
Ranolazine—SCN5A—L1CAM interactions—EGFR—dilated cardiomyopathy	4.6e-05	0.00529	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—RAC1—dilated cardiomyopathy	4.38e-05	0.00504	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—RAF1—dilated cardiomyopathy	4.07e-05	0.00468	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—RAC1—dilated cardiomyopathy	3.83e-05	0.0044	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—ITGB1—dilated cardiomyopathy	3.4e-05	0.0039	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	2.97e-05	0.00342	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—RAF1—dilated cardiomyopathy	2.91e-05	0.00334	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—CD36—dilated cardiomyopathy	2.9e-05	0.00333	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—EGFR—dilated cardiomyopathy	2.79e-05	0.00321	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—RAC1—dilated cardiomyopathy	2.73e-05	0.00314	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—RAF1—dilated cardiomyopathy	2.54e-05	0.00292	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—EGFR—dilated cardiomyopathy	1.99e-05	0.00229	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—TNF—dilated cardiomyopathy	1.9e-05	0.00218	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—RAF1—dilated cardiomyopathy	1.81e-05	0.00208	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—EGFR—dilated cardiomyopathy	1.74e-05	0.002	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	1.6e-05	0.00183	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	1.5e-05	0.00172	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	1.36e-05	0.00156	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—EGFR—dilated cardiomyopathy	1.24e-05	0.00143	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—TNF—dilated cardiomyopathy	1.18e-05	0.00136	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	1.04e-05	0.0012	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	9.81e-06	0.00113	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	8.87e-06	0.00102	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	3.68e-06	0.000423	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	3.59e-06	0.000412	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	3.23e-06	0.000371	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	2.41e-06	0.000277	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	2.35e-06	0.00027	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	2.11e-06	0.000243	CbGpPWpGaD
